Showing 521 - 540 results of 805 for search '"Demyelinating disease"', query time: 0.12s Refine Results
  1. 521

    Long‐term clinical, imaging and cognitive outcomes association with MS immunopathology by Alicja Kalinowska‐Lyszczarz, Jan‐Mendelt Tillema, William Oliver Tobin, Yong Guo, Stephen D. Weigand, Imke Metz, Wolfgang Brück, Hans Lassmann, Monica Giraldo‐Chica, John D. Port, Claudia F. Lucchinetti

    Published 2023-03-01
    “…Abstract Objective In this observational study on a cohort of biopsy‐proven central nervous system demyelinating disease consistent with MS, we examined the relationship between early‐active demyelinating lesion immunopattern (IP) with subsequent clinical course, radiographic progression, and cognitive function. …”
    Get full text
    Article
  2. 522

    IFNα and β Mediated JCPyV Suppression through C/EBPβ-LIP Isoform by Dana May, Anna Bellizzi, Workineh Kassa, John M. Cipriaso, Maurizio Caocci, Hassen S. Wollebo

    Published 2021-09-01
    “…Polyomavirus JC (JCPyV) causes the demyelinating disease progressive multifocal leukoencephalopathy (PML). …”
    Get full text
    Article
  3. 523

    piRNA and miRNA Can Suppress the Expression of Multiple Sclerosis Candidate Genes by Saltanat Kamenova, Aksholpan Sharapkhanova, Aigul Akimniyazova, Karlygash Kuzhybayeva, Aida Kondybayeva, Aizhan Rakhmetullina, Anna Pyrkova, Anatoliy Ivashchenko

    Published 2022-12-01
    “…Multiple sclerosis (MS) is a common inflammatory demyelinating disease with a high mortality rate. MS is caused by many candidate genes whose specific involvement has yet to be established. …”
    Get full text
    Article
  4. 524

    G Protein Coupled Receptors Potentially Involved in Oligodendrogenesis: A Gene Expression Analysis by Neda Karami, Hadi Aligholi, Moosa Rahimi, Hassan Azari, Tahereh kalantari

    Published 2022-10-01
    “… Background: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system characterized by infiltration of inflammatory leukocytes to the CNS followed by oligodendrocyte cell death, myelin sheath destruction, and axonal injury. …”
    Get full text
    Article
  5. 525

    Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Mode... by Victor Longoria, Hannah Parcel, Bameelia Toma, Annu Minhas, Rana Zeine

    Published 2022-02-01
    “…A systematic review was conducted by a literature search through PubMed, ProQuest, and EBSCO electronic databases for studies reported since 2007 on the use of cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) in MS and in experimental autoimmune encephalomyelitis (EAE), Theiler’s murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD), and toxin-induced demyelination models. …”
    Get full text
    Article
  6. 526

    The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study by Di He, Liyang Liu, Dongchao Shen, Peng Zou, Liying Cui, Liying Cui

    Published 2022-05-01
    “…ObjectivesMultiple sclerosis (MS) is a complex central nervous system (CNS) demyelinating disease, the etiology of which involves the interplay between genetic and environmental factors. …”
    Get full text
    Article
  7. 527

    Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation. by Athanasia Mouzaki, Maria Rodi, Nikolaos Dimisianos, Andreas Emmanuil, Dimitra Kalavrizioti, Rosa Lagoudaki, Nikolaos C Grigoriadis, Panagiotis Papathanasopoulos

    Published 2015-01-01
    “…Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Effector T helper cells, mainly Th1 and Th17, cytotoxic T-cells, B-cells, macrophages, microglia, and the cytokines they secrete, are implicated in the initiation and maintenance of a deregulated immune response to myelin antigens and the ensuing immune-mediated demyelination. …”
    Get full text
    Article
  8. 528

    Recent Considerations on Gaming Console Based Training for Multiple Sclerosis Rehabilitation by Antonio Celesti, Vincenzo Cimino, Antonino Naro, Simona Portaro, Maria Fazio, Massimo Villari, Rocco Salvatore Calabró

    Published 2022-02-01
    “…Multiple Sclerosis (MS) is a well-known, chronic demyelinating disease of the Central Nervous System (CNS) and one of the most common causes of disability in young adults. …”
    Get full text
    Article
  9. 529

    Acute Necrotizing Hemorrhagic Leukoencephalitis by Fatma Ece Bayam, Gülgün Ersöz, Eren Demirtaş, Gülgün Yılmaz Ovalı, Ayşe Sağduyu Kocaman

    Published 2008-08-01
    “…Scientific BACKGROUND: Acute necrotizing hemorrhagic leukoencephalitis (ANHL) is a rare, demyelinating disease of white matter, characterized with fibrinoid necrozis. …”
    Get full text
    Article
  10. 530

    TNFR2 Signaling Regulates the Immunomodulatory Function of Oligodendrocyte Precursor Cells by Haritha L. Desu, Placido Illiano, James S. Choi, Maureen C. Ascona, Han Gao, Jae K. Lee, Roberta Brambilla

    Published 2021-07-01
    “…Furthermore, we demonstrated that TNFR2 plays a key role in this process, suggesting that boosting TNFR2 activation or its downstream signals could be an effective strategy to restore OPC reparative capacity in demyelinating disease.…”
    Get full text
    Article
  11. 531

    Multiple sclerosis disease-modifying drug use by immigrants: a real-world study by Jonas Graf, Huah Shin Ng, Feng Zhu, Yinshan Zhao, José M. A. Wijnands, Charity Evans, John D. Fisk, Ruth Ann Marrie, Helen Tremlett

    Published 2023-12-01
    “…The index date was the first MS-related healthcare encounter (MS/demyelinating disease-related diagnosis or DMD prescription filled), and ranged from 01/January/1996 to 31/December/2012. …”
    Get full text
    Article
  12. 532

    Predictors of severity and outcome of multiple sclerosis relapses by Hassan Saad Hosny, Hatem Samir Shehata, Sandra Ahmed, Ismail Ramadan, Sarah Sherif Abdo, Amr Mohamed Fouad

    Published 2023-02-01
    “…Abstract Background Multiple Sclerosis (MS) is a demyelinating disease of the central nervous system (CNS). …”
    Get full text
    Article
  13. 533

    Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? by Evgenia Emmanouilidou, Despoina Kosmara, Efrosini Papadaki, Vasileios Mastorodemos, Pantelis Constantoulakis, Argyro Repa, Georgia Christopoulou, Christina Kalpadakis, Nestor Avgoustidis, Konstantinos Thomas, Dimitrios Boumpas, Prodromos Sidiropoulos, George Bertsias

    Published 2023-11-01
    “…Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating disease of the central nervous system (CNS) caused by reactivation of the polyomavirus JC (JCV) typically in immunocompromised individuals. …”
    Get full text
    Article
  14. 534

    The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis by Massimiliano Castellazzi, Caterina Ferri, Ginevra Tecilla, André Huss, Paola Crociani, Gaetano Desina, Gianvito Barbella, Alice Piola, Samantha Permunian, Makbule Senel, Maurizio Leone, Hayrettin Tumani, Maura Pugliatti

    Published 2022-06-01
    “…(1) Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) that mainly affects young adults and females more than males. …”
    Get full text
    Article
  15. 535

    The effects of neuroinflammation on the subventricular zone neurogenic compartment following Theiler's Murine Encephalomyelitis virus infection and its regulation by Galectin-3 by James, RE

    Published 2012
    “…Theiler's murine encephalomyelitis virus (TMEV) induces a demyelinating disease in susceptible SJL/J mice, due to persistence of the virus, which models the chronic progressive form of multiple sclerosis. …”
    Thesis
  16. 536

    Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review by Cong Zhao, Pei Liu, Daidi Zhao, Jiaqi Ding, Guangyun Zhang, Hongzeng Li, Jun Guo

    Published 2022-07-01
    “…Background: Myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG) has been considered a diagnostic marker for patients with demyelinating disease, termed “MOG-IgG associated disorder” (MOGAD). …”
    Get full text
    Article
  17. 537
  18. 538

    Assessment of PD-1 gene variation in patients with multiple sclerosis by Shadmehri AA, Nicknam MH, Shokrgozar MA, Mahmoudi M, Sarial Sh, Ahmadi Shadmehri A, Moradi B, Farhadi E, Amirzargar AA

    Published 2010-05-01
    “…"n Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New Roman"; mso-fareast-theme-font:minor-fareast; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:Arial; mso-bidi-theme-font:minor-bidi;} Background: Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system with presumed autoimmune origin. …”
    Get full text
    Article
  19. 539

    CNS demyelinating events in primary Sjögren's syndrome: A single-center case series on the clinical phenotype by Ali M. Afzali, Ali M. Afzali, Philipp Moog, Sudhakar Reddy Kalluri, Benedikt Hofauer, Andreas Knopf, Andreas Knopf, Jan Stefan Kirschke, Bernhard Hemmer, Bernhard Hemmer, Achim Berthele

    Published 2023-02-01
    “…ObjectiveThe study aimed to assess the prevalence, clinical characteristics, and therapeutic outcomes of the central nervous system (CNS) demyelinating disease in a large cohort of primary Sjögren's syndrome (pSS).MethodsThis is an explorative cross-sectional study of patients with pSS seen in the departments of rheumatology, otorhinolaryngology, or neurology of a tertiary university center between January 2015 and September 2021.ResultsIn a cohort of 194 pSS patients, 22 patients had a CNS manifestation. …”
    Get full text
    Article
  20. 540

    Ursolic acid derivative UAOS-Na treats experimental autoimmune encephalomyelitis by immunoregulation and protecting myelin by Maolin Wang, Maolin Wang, Chenming Gu, Yifu Yang, Liang Chen, Kaixian Chen, Jun Du, Huali Wu, Yiming Li

    Published 2023-11-01
    “…IntroductionMultiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). …”
    Get full text
    Article